ANC 0 3 0 3 B-clinical_variable
> 4 5 4 5 O
500 5 8 5 8 B-lower_bound
/ 8 9 8 9 I-lower_bound
mm3 9 12 9 12 I-lower_bound

Creatinine 0 10 13 23 B-clinical_variable
clearance 11 20 24 33 I-clinical_variable
> 21 22 34 35 O
70ml 22 26 35 39 B-lower_bound
/ 26 27 39 40 I-lower_bound
min/1.73m2 27 37 40 50 I-lower_bound

Karnofsky 0 9 51 60 B-clinical_variable
performance 10 21 61 72 I-clinical_variable
status 22 28 73 79 I-clinical_variable
> 29 30 80 81 O
50 30 32 81 83 B-lower_bound
% 32 33 83 84 I-lower_bound

Life 0 4 85 89 B-clinical_variable
expectancy 5 15 90 100 I-clinical_variable
> 16 17 101 102 O
8 18 19 103 104 B-lower_bound
weeks 20 25 105 110 I-lower_bound

Must 0 4 111 115 O
have 5 9 116 120 O
unresectable 10 22 121 133 O
primary 23 30 134 141 B-cancer
tumor 31 36 142 147 I-cancer
or 37 39 148 150 O
metastases 40 50 151 161 B-cancer

Patient 0 7 162 169 O
may 8 11 170 173 O
not 12 15 174 177 B-pregnancy
be 16 18 178 180 I-pregnancy
pregnant 19 27 181 189 I-pregnancy
or 28 30 190 192 O
breastfeeding 31 44 193 206 O

Patients 0 8 207 215 O
must 9 13 216 220 O
be 14 16 221 223 O
between 17 24 224 231 O
13 25 27 232 234 B-lower_bound
and 28 31 235 238 O
65 32 34 239 241 B-upper_bound
years 35 40 242 247 I-upper_bound
of 41 43 248 250 O
age 44 47 251 254 B-age

Patients 0 8 255 263 O
who 9 12 264 267 O
have 13 17 268 272 O
received 18 26 273 281 O
prior 27 32 282 287 B-treatment
radiotherapy 33 45 288 300 I-treatment
to 46 48 301 303 O
all 49 52 304 307 O
areas 53 58 308 313 O
of 59 61 314 316 O
current 62 69 317 324 O
active 70 76 325 331 O
disease 77 84 332 339 O

Platelets 0 9 340 349 B-clinical_variable
> 10 11 350 351 O
50,000 11 17 351 357 B-lower_bound
/ 17 18 357 358 I-lower_bound
mm3 18 21 358 361 I-lower_bound

